论文部分内容阅读
目的分析复方制剂缬沙坦氨氯地平治疗高血压的效果。方法选取我院2014年1月~2015年10月收治的高血压患者83例作为研究对象,将其随机分为对照组41例与观察组42例。对照组患者采用氨氯地平联合缬沙坦进行治疗,观察组患者采用复方制剂缬沙坦氨氯地平进行治疗,观察两组患者治疗后血压达标率、血压的变化情况以及并发症发生率。结果对照组患者治疗后血压达标率低于观察组(P<0.05),其血压下降幅度小于观察组(P<0.05),对照组的并发症发生率为31.71%,高于观察组的11.90%,差异有统计学意义(P<0.05)。结论与氨氯地平联合缬沙坦治疗相比,复方制剂缬沙坦氨氯地平能更有效地降低患者血压,还能提高其血压达标率,值得临床推广。
Objective To analyze the effect of valsartan amlodipine in the treatment of hypertension. Methods Totally 83 hypertensive patients admitted to our hospital from January 2014 to October 2015 were selected as study subjects and randomly divided into control group (n = 41) and observation group (n = 42). Patients in the control group were treated with amlodipine combined with valsartan. The patients in the observation group were treated with valsartan amlodipine. The compliance rate of blood pressure, blood pressure and complication rate were observed after treatment in both groups. Results The blood pressure compliance rate of the control group was lower than that of the observation group (P <0.05), and the decrease of blood pressure was less than that of the observation group (P <0.05). The complication rate of the control group was 31.71%, higher than that of the observation group (11.90% , The difference was statistically significant (P <0.05). Conclusions Compared with amlodipine and valsartan, valsartan and amlodipine can reduce blood pressure more effectively and improve blood pressure compliance rate, which is worthy of clinical promotion.